Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.


BACKGROUND/AIMS Hepatic fibrosis contributes to adverse outcome in cystic fibrosis (CF). Early detection of CF liver disease (CFLD) may identify patients at risk of significant complications. To evaluate the utility of serum markers to detect hepatic fibrosis in children with CFLD vs. CF patients without liver disease (CFnoLD) and controls. METHODS Sera… (More)


  • Presentations referencing similar topics